Skip to ContentSkip to Navigation
About usNews and EventsNews articles

Little known about optimum diabetes care for the over-75s

06 February 2013

Doubts have arisen about whether the current treatment strategies for diabetes patients over 75 are always the best. There is little substantiated knowledge about treating this group, and adverse effects resulting from current strategies cannot be ruled out. Interventions used to treat diabetes and manage other risk factors for cardiovascular disease in patients over 75 years of age could be less stringent. This is the conclusion drawn by researcher Hans van Hateren after a long-term study in the Diabetes Knowledge Centre in Zwolle. He will be awarded a PhD by the University of Groningen on Wednesday 13 February.

The number of people with diabetes is high and still rising. More than a quarter of them are over 75. Yet very little is known about the effects that glucose regulation or medication to lower blood pressure have on this group. The benefits for younger patients are undisputed. The over-75s, however, are often under-represented in large-scale scientific studies, which is why doubts are arising about the current treatment strategies for this growing group of patients. Van Hateren hopes that his research will add scientific weight to decisions on treatment options for patients over 75 years old.

Risk factors have different implications

His research shows that the implications of traditional risk factors for cardiovascular disease (blood pressure, cholesterol and glycaemic regulation) are different for this group than for younger patients. For example, older people with raised blood pressure have a longer life expectancy. This makes it difficult to gauge the extent to which their blood pressure, cholesterol and blood sugar levels should be reduced. Although evidence supporting the beneficial effects of medication for this group is scant, it is still the group most commonly treated for these conditions.

Ask about dizziness

Van Hateren also concludes that a drop in blood pressure on standing up (orthostatic hypotension) is very common among older people with diabetes; this increases the risk of falling. A drop in blood pressure of this kind is considered to be a side-effect of the medication taken to lower the blood pressure. He recommends asking this group regularly whether they feel dizzy or light-headed, as this is simpler than trying to measure orthostatic hypotension.

Define individual treatment aims

Van Hateren comes to the conclusion that it is very important to define the aim of treatment in older patients. He wonders whether it would be better to keep the risk of cardiovascular disease to a minimum or aim for the best possible quality of life. The estimated life expectancy and vulnerability of elderly people should be important factors when weighing up the pros and cons. Van Hateren stresses the case for defining individual aims and target values.

Curriculum Vitae

Hans van Hateren (Hardenberg, 1983) studied Medicine at the University of Groningen. He conducted his PhD research in the Diabetes Knowledge Centre at the Isala Clinics in Zwolle, as part of the long-running ZODIAC study. His thesis is entitled: ‘Diabetes care in old age’. He works as a General Practitioner trainee at the UMCG and as a physician-researcher at the Diabetes Knowledge Centre in Zwolle.

Last modified:15 September 2017 3.31 p.m.
printView this page in: Nederlands

More news

  • 15 November 2019

    Retirement Jan de Jeu: Board member from outside

    On Friday 15 November 2019, Jan de Jeu will retire from his position in the Board of the University of Groningen after eight years in office. When Jan de Jeu was appointed, it was the first time that the UG broke the tradition of only recruiting board...

  • 15 November 2019

    Hong Kong update: safety first

    We are very concerned regarding the current situation in Hong Kong, especially near some of the premises of our partner universities. The University of Hong Kong, the Chinese University of Hong Kong, and Hong Kong Baptist University have informed us...

  • 07 November 2019

    Astronomers map new emission line to trace most common molecule in the Universe

    Molecular hydrogen (H2) makes up 99% of the cold dense gas in galaxies. So mapping where stars are born basically means measuring H2, which lacks a strong characteristic signature at low temperatures. Astronomers from SRON Netherlands Institute for...